Icecure Medical Ltd (NASDAQ: ICCM) on Monday, plunged -6.77% from the previous trading day, before settling in for the closing price of $0.65. Within the past 52 weeks, ICCM’s price has moved between $0.48 and $1.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 33.95% annually for the last half of the decade. The company achieved an average annual earnings per share of 13.54%. With a float of $24.12 million, this company’s outstanding shares have now reached $45.73 million.
In an organization with 77 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 40.37%, operating margin of -429.36%, and the pretax margin is -407.16%.
Icecure Medical Ltd (ICCM) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Icecure Medical Ltd is 51.28%, while institutional ownership is 0.73%.
Icecure Medical Ltd (ICCM) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.09 earnings per share (EPS) for the period topping the consensus outlook (set at -0.09) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.54% per share during the next fiscal year.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
Icecure Medical Ltd (ICCM) is currently performing well based on its current performance indicators. A quick ratio of 2.54 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.92 million. That was better than the volume of 0.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.31%. Additionally, its Average True Range was 0.08.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 30.69%, which indicates a significant increase from 21.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 130.33% in the past 14 days, which was higher than the 74.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6383, while its 200-day Moving Average is $0.9273. However, in the short run, Icecure Medical Ltd’s stock first resistance to watch stands at $0.6714. Second resistance stands at $0.7339. The third major resistance level sits at $0.8021. If the price goes on to break the first support level at $0.5407, it is likely to go to the next support level at $0.4725. The third support level lies at $0.4100 if the price breaches the second support level.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
Market capitalization of the company is 26.61 million based on 45,623K outstanding shares. Right now, sales total 3,230 K and income totals -14,650 K. The company made 1,010 K in profit during its latest quarter, and -3,080 K in sales during its previous quarter.
